Offer - Urjas Oil for just ₹ 1 X
Esiflo HFA, a prescription drug, is manufactured in various forms such as Inhaler. Esiflo HFA also has some secondary and off-label uses. These are listed below.
The optimal dosage of Esiflo HFA is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Esiflo HFA are Shortness of Breath, Throat Irritation, Nosebleed. Apart from the aforementioned side effects, Esiflo HFA can also lead to other problems, which have been listed below. These side effects of Esiflo HFA are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Esiflo HFA is Moderate for pregnant women and Mild for women who are breastfeeding. In addition, Esiflo HFA's effects on the liver, heart and kidney are discussed below in the Esiflo HFA related warnings section.
Other contraindications of Esiflo HFA have been discussed in the sections ahead.
Additionally, Esiflo HFA may also adversely react with other medicines. Refer to the list below for further details.
You should also be aware that Esiflo HFA is safe while driving, and is addiction.
Esiflo HFA is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Esiflo HFA safe for pregnant women?
Esiflo HFA can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Esiflo HFA right away. Take your doctor's advice before taking it again.
Is the use of Esiflo HFA safe during breastfeeding?
Breastfeeding women can take Esiflo HFA as it bears very minor side effects for them.
What is the effect of Esiflo HFA on the Kidneys?
Using Esiflo HFA does not have any harmful effects on kidneys.
What is the effect of Esiflo HFA on the Liver?
You may experience side effects on your liver after taking Esiflo HFA. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Esiflo HFA on the Heart?
There may be an adverse effect on the heart after taking Esiflo HFA. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Esiflo HFA should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Esiflo HFA unless your doctor advises you to do so -
Is this Esiflo HFA habit forming or addictive?
Esiflo HFA does not cause addiction.
Interaction between Food and Esiflo HFA
There is no information on the effects of taking Esiflo HFA with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Esiflo HFA
No research has been done on this till date. Therefore, it is not known what the effect of taking Esiflo HFA with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359